On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning
- 31 January 2004
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 70 (1) , 11-19
- https://doi.org/10.1016/j.radonc.2003.11.013
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancerRadiotherapy and Oncology, 2003
- A model to simulate day-to-day variations in rectum shapeInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 reportRadiotherapy and Oncology, 2002
- Late rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose–volume histogramsInternational Journal of Radiation Oncology*Biology*Physics, 2001
- 1008 Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume?International Journal of Radiation Oncology*Biology*Physics, 1999
- Dose–wall histograms and normalized dose–surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Analysis of the dose‐surface histogram and dose‐wall histogram for the rectum and bladderMedical Physics, 1997
- Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995